New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)

Bibliographic Details
Main Authors:	Anna S. Berghoff, Angelika M. Starzer
Format:	Article
Language:	English
Published:	Elsevier 2019-06-01
Series:	ESMO Open
Online Access:	https://esmoopen.bmj.com/content/4/Suppl_3/e000629.full

id	doaj-326e675131f94256932b6806253cccfc
record_format	Article
spelling	doaj-326e675131f94256932b6806253cccfc2021-04-02T20:44:55ZengElsevierESMO Open2059-70292019-06-014Suppl 310.1136/esmoopen-2019-000629New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)Anna S. Berghoff0Angelika M. Starzer11 Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austriahttps://esmoopen.bmj.com/content/4/Suppl_3/e000629.full
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Anna S. Berghoff Angelika M. Starzer
spellingShingle	Anna S. Berghoff Angelika M. Starzer New emerging targets in cancer immunotherapy: CD27 (TNFRSF7) ESMO Open
author_facet	Anna S. Berghoff Angelika M. Starzer
author_sort	Anna S. Berghoff
title	New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
title_short	New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
title_full	New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
title_fullStr	New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
title_full_unstemmed	New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
title_sort	new emerging targets in cancer immunotherapy: cd27 (tnfrsf7)
publisher	Elsevier
series	ESMO Open
issn	2059-7029
publishDate	2019-06-01
url	https://esmoopen.bmj.com/content/4/Suppl_3/e000629.full
work_keys_str_mv	AT annasberghoff newemergingtargetsincancerimmunotherapycd27tnfrsf7 AT angelikamstarzer newemergingtargetsincancerimmunotherapycd27tnfrsf7
_version_	1721546594164146176

New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)

Similar Items